Effects of PCSK9 Inhibitor on Favorable Limb Outcomes in Patients with Chronic Limb-Threatening Ischemia

Aim: The aim of this study was to examine the effects of evolocumab on favorable limb events in patients with chronic limb-threatening ischemia (CLTI). Methods: A single-center, prospective observational study was performed on 30 patients with CLTI. The subjects were divided into 2 groups based on e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yusuke, Uzui, Hiroyasu, Morishita, Tetsuji, Fukuoka, Yoshitomo, Hasegawa, Kanae, Ikeda, Hiroyuki, Tama, Naoto, Ishida, Kentaro, Miyazaki, Shinsuke, Tada, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265925/
https://www.ncbi.nlm.nih.gov/pubmed/32981918
http://dx.doi.org/10.5551/jat.57653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265925/
https://www.ncbi.nlm.nih.gov/pubmed/32981918
http://dx.doi.org/10.5551/jat.57653

Ejemplares similares